Use of CMV unselected blood products does not increase the risk of CMV reactivation in patients undergoing hematopoetic stem cell transplant (HSCT).
Peters, Jayne Elliott, Jonathon Bloor, Adrian Dennis, Michael Murray, John Cavet, James Somervaille, Tim C P Sommerfeld, Sven A Mutton, Ken Mamat, Mohd K
Peters, Jayne
Elliott, Jonathon
Bloor, Adrian
Dennis, Michael
Murray, John
Cavet, James
Somervaille, Tim C P
Sommerfeld, Sven A
Mutton, Ken
Mamat, Mohd K
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2015
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Use of CMV unselected blood products does not increase the risk of CMV reactivation in patients undergoing hematopoetic stem cell transplant (HSCT). 2015, 126 (23): Blood